Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-17

FDA Approved: OXAPROZIN — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for Oxaprozin submitted by Dr. Reddy's Laboratories Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxaprozin (Oxaprozin)

Snippet

SUPPL AP for OXAPROZIN (OXAPROZIN)